CAS:152074-97-0:Dirucotide

Send Inquiry
CAS:152074-97-0:Dirucotide
Details
CAS: 152074-97-0
Sequence: Asp-Glu-Asn-Pro-Val-Val-His-Phe-Phe-Lys-Asn-Ile-Val-Thr-Pro-Arg-Thr (myelin basic protein MBP 83-99 native linear 17-mer peptide)
We also provide specifications from crude to 99% purity. please contact us for details!
Related documents
COA/MS/HPLC Report
Peptide Dissolution and Storage Guide
Category
Immune Tolerance Peptide / Multiple Sclerosis Autoimmune Peptide
Category
Pharmaceutical Peptides
Share to
Description

Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of cas:152074-97-0:dirucotide in China, also supports custom service. Welcome to wholesale bulk high quality cas:152074-97-0:dirucotide from our factory. Contact us for more details.

 

Product Name CAS:152074-97-0:Dirucotide
Description Dirucotide (MBP 8298) is a native 17-mer peptide fragment of human myelin basic protein, corresponding to the MBP amino acid sequence 83-99. It induces immune tolerance in myelin-specific autoreactive T cells, reduces autoimmune attack on central nervous system myelin, and delays the progression of multiple sclerosis. Applied in autoimmune demyelinating diseases, immune tolerance mechanism and peptide vaccine research.
Peptide Purity (HPLC, %) 95% / 98% / 99%
Structure type Native myelin protein-derived linear 17-mer peptide, no chemical modification
Molecular Weight (Da) ~1960

 

Product Basic Information Table

 

Product Standard English Name Product Abbreviation / Alias Function Tags (comma-separated) Full Amino Acid Sequence Molecular Formula Exact Mass (Da) Average MW (Da) N-terminal Modification C-terminal Modification Length (aa)
Dirucotide Dirucotide; MBP 8298; Myelin basic protein peptide; CAS 152074-97-0 Immune tolerance induction,Multiple sclerosis study,Myelin protection,Autoimmune disease,T cell epitope peptide,Peptide vaccine Aspartic acid-glutamic acid-asparagine-proline-valine-valine-histidine-phenylalanine-phenylalanine-lysine-asparagine-isoleucine-valine-threonine-proline-arginine-threonine Large polypeptide, no precise small-molecule formula; subject to actual batch MS - ~1960 (theoretical) Free amine, no modification Free carboxyl, no modification 17

Physicochemical Solubility & Storage Parameters

 

Product Code Appearance Long-term Storage Conditions Short-term Storage Conditions Liquid Stability Solid Powder Stability
PEP-DRC001 white powder Store at -20℃, sealed, dry & protected from light, aliquoted; avoid repeated freeze-thaw cycles Solid powder stable for 1 year at 2-8℃ sealed & dry; prepare aqueous solutions freshly before use Stable for 48 h at 4℃; stable for 2 weeks at -20℃ in aliquots. **Good water solubility, freely soluble in water and physiological buffer**. Unmodified native long peptide easily degraded by peptidases with rapid activity decay at room temperature. Histidine and tyrosine prone to photooxidation Stable for 2 years at -20℃ under dry & dark conditions

Functional Description

 

Product Code Frontend Short Summary (for search list display) Detailed Biological Function Description Applicable Research Areas (comma-separated) Targets / Pathways
PEP-DRC001 Native myelin basic protein 17-mer peptide that induces autoimmune tolerance and delays demyelination progression in multiple sclerosis Dirucotide is a native T cell epitope peptide derived from human myelin basic protein (MBP), corresponding to the immunodominant epitope at positions 83-99 of the MBP molecule. After uptake by antigen-presenting cells, it is presented to autoreactive CD4+ T cells via MHC class II molecules, inducing T cell anergy, apoptosis or conversion to regulatory T cells, establishing immune tolerance to myelin antigens, thereby reducing T cell-mediated central nervous system myelin damage and demyelinating lesions, and delaying the progression of multiple sclerosis. This peptide is a native endogenous protein fragment with mild immunogenicity and no obvious toxic side effects. It serves as a core tool molecule for multiple sclerosis immunotherapy research, autoimmune tolerance mechanism analysis, myelin antigen epitope identification, and peptide vaccine SAR optimization. Multiple sclerosis research,Autoimmune disease study,Immune tolerance mechanism,Demyelinating disease study,T cell epitope research,Peptide vaccine development MHC class II molecule-peptide complex; Myelin-specific autoreactive T cells; Central immune tolerance regulatory pathway

 

 

 

 

 

 

Hot Tags: cas:152074-97-0:dirucotide, China cas:152074-97-0:dirucotide manufacturers, suppliers, factory, 2381089-83-2, 910463-68-2, CAS 137525 51 0, CAS 910463 68 2, Melanotan I acetate, pharmaceutical peptides

Send Inquiry